Table 1 Characteristics of patients
From: RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker
Characteristic | No. of patients (%) |
|---|---|
Sex | |
Male | 27 (39.7) |
Female | 41 (60.3) |
Age at diagnosis | |
<12 months | 42 (61.8) |
⩾12 months | 26 (38.2) |
Stage | |
1 | 24 (35.3) |
2 | 11 (16.2) |
3 | 11 (16.2) |
4 | 18 (26.5) |
4S | 4 (5.9) |
MYCN | |
Non-amplified | 56 (82.4) |
Amplified | 12 (17.6) |
Diagnosis | |
GNB | 7 (10.3) |
NB | 61 (89.7) |
Serum RASSF1A | |
Unmethylated | 51 (75.0) |
Methylated | 17 (25.0) |
